Alveolusbio
1 known investors
Alveolus Bio develops inhaled biotherapeutics using a proprietary platform to deliver engineered bacteria directly to the lungs for treating chronic lung diseases including idiopathic pulmonary fibrosis, bronchiectasis, and COPD. The company targets patients with fibrotic and inflammatory lung conditions.
BiotechDigital HealthMedical Devices